Timeline
We released a high-level summary of submissions to Consultation Paper 9. This was stage 1 of the consultation.
We are now planning stage 2, which will involve discussions with stakeholder groups.
Past activities
Date | Activity |
---|---|
12 July – 6 September 2024 | Sought stakeholders’ views on how to implement the MSAC advice and reduce benefits for technical support services, via Consultation paper 9 . This was stage 1 of the consultation. |
1 July 2024 | Second scheduled benefit reduction of 20% of the gap (device component only) |
19 April 2024 | Announced next steps for benefit reductions for CIED after MSAC advice. The proportion of the benefit corresponding to the device component was recalculated at 56.3%. |
16 April 2024 | The MSAC provided advice on the reasonable cost of technical support services for CIEDs |
1 July 2023 | First scheduled benefit reduction of 40% of the gap on 1 July 2023 (device component only). See the updated benefits. The device component of the CIED benefit was estimated at 54% of the current CIED benefit. We based this estimate on the information provided to the MSAC by the industry applicant. |
7 June 2023 | Published revised reduced CIED benefits (device component only) PHI 36/23 Revised benefit reductions for Cardiac Implantable Electronic Devices. |
16 May 2023 | Published reduced CIED benefits (device component only) effective 1 July 2023 PHI 29/23 Benefit reductions to Cardiac Implantable Electronic Devices. |
January to February 2023 | We worked with the Medical Technology Association of Australia (MTAA) Cardiac Forum on an interim solution: reduce CIED benefits for the device component only, effective 1 July 2023. |
Date last updated: